| Literature DB >> 23542243 |
Fabien Reyal1, Jean-Guillaume Feron, Solene Leman Detour, Anne Gaelle Pourcelot, Morgane Valentin, Anne-Cecile Phillippe, Yaelle Levy-Zauberman, Antoine Agman, Sindy Monier, Anne Blondel, Isabelle Cothier-Savey, Thierry Guihard, Perig Le Masurier, Alfred Fitoussi, Benoit Couturaud.
Abstract
In March of 2010, French authorities suspended the use of breast implants made by the company Poly Implant Prothèse. Institut Curie is a large cancer center, and Poly Implant Prothèse was one major silicone-filled breast implant brand used. This report describes the impact of the fraudulent implants worldwide and more specifically on patient care at the authors' unit. From 2002 to 2009, the median number of Poly Implant Prothèse implants removed per year was 32. Since the first alert in March of 2010, 252 of these breast implants were removed in 2010 and 2011. The breast implants removed were mainly reported as normal, with a rupture rate of less than 5 percent before 2008. However, the annual rupture rate has increased from 2008 to 2011 (8, 14, 20, and 23 percent, respectively). The Institut Curie, in conjunction with breast cancer patients, has organized a management plan to deal with this major industrial fraud. Its surveillance program of breast cancer patients facilitated the management of patients during this difficult time.Entities:
Mesh:
Year: 2013 PMID: 23542243 DOI: 10.1097/PRS.0b013e3182827605
Source DB: PubMed Journal: Plast Reconstr Surg ISSN: 0032-1052 Impact factor: 4.730